Evaluating the effectiveness of reformulated extended-release oxycodone with abuse-deterrent properties on reducing non-oral abuse among individuals assessed for substance abuse treatment with the Addiction Severity Index-Multimedia Version (ASI-MV)
Author:
Affiliation:
1. Janssen Pharmaceuticals, LLC, Raritan, NJ, USA
2. Uprise Health/Inflexxion, Irvine, CA, USA
3. Ephicacy Consulting Group, Iselin, NJ, USA
Funder
Purdue Pharma
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2023.2178080
Reference27 articles.
1. OxyContin (oxycodone hydrochloride) Extended-Release Tablets. Full prescribing information. Purdue Pharma L.P; [accessed 2022 Aug 2]. Available from: http://app.purduepharma.com/xmlpublishing/pi.aspx?id=o
2. A Profile of OxyContin Addiction
3. Non-Medical Use of OxyContin Tablets in the United States
4. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic
5. Total Necrosis of the Intranasal Structures and Soft Palate as a Result of Nasal Inhalation of Crushed Oxycontin
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3